Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review

Updated review (17 studies, approx. 23,565 patients) reports ACEI or ARB use is not associated with more severe COVID-19 disease and suggests no association between use of these medications and positive SARS-CoV-2 test results among symptomatic patients.


Annals of Internal Medicine